This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Microcap Article: Archive
BIAF Stock Surges Post Improved Earnings and Record 2024 Revenues
by Zacks Equity Research
bioAffinity witnesses record 2024 revenues, driven by CyPath Lung adoption, Medicare coverage and strategic expansion across healthcare networks.
BIAFNegative Net Change
biotechnology biotechs earnings medical
Blue Dolphin Posts 2024 Loss Amid Margin & Liquidity Pressures
by Zacks Equity Research
BDCO swings to a loss in 2024 as weak margins, lower sales and rising impairments weigh on results. Liquidity and working capital also decline.
BDCOPositive Net Change
earnings energy oil-energy
VASO Stock Rises Post Q4 Revenue Growth and Solid Segment Gains
by Zacks Equity Research
Vaso's fourth-quarter 2024 results reflect record revenue and strong segment growth despite a decline in full-year profit due to higher operating expenses.
VASONegative Net Change
earnings medical medical-devices
Zacks April View on Equity Markets
by John Blank
In the prior 10 instances, of the S&P500 falling -10% from a record high in 20 days or fewer, we have a nice record to mine for insights.
asset-allocation
ZRS Chart of the Month
by John Blank
Info Tech remains overpriced, at extreme valuations, still +37% over the median. That is the remaining AI "froth factor." Factor in high tech mega-cap P/E multiples too.
asset-allocation
April Asset Allocation Guidelines
by John Blank
5 different frameworks specify portfolio risk tolerance: from Risky "Max Growth" to Conservative "Income." Choose one that fits you.
asset-allocation
April Sell-Side and Buy-Side - Consensus at a Glance
by John Blank
A valuation boost from the attraction of a broad equity risk premium looks OK using Zacks 2025 S&P500 earnings of $267.82.
asset-allocation
International: Update on Global Regions
by John Blank
The S&P index is more global than one may think. Many U.S. corporations have a global presence, with assets and revenues in or from foreign countries.
asset-allocation
Jones Soda Q4 Loss Widens Y/Y as Sales Drop & Expenses Climb
by Zacks Equity Research
JSDA Q4 revenues drop 20% y/y, net loss widens. The company targets margin recovery, zero-calorie launches and THC market expansion in 2025.
JSDAPositive Net Change
consumer-staples earnings
Zacks Initiates Coverage of Franklin Financial With Outperform Recommendation
by Urbashi Dutta
Discover why Zacks, being the first on Wall Street to initiate the stock coverage, rates Franklin Financial as "Outperform." Explore how FRAF excels in loan, deposit and wealth growth, rewarding shareholders while managing margin and liquidity challenges.
FRAFPositive Net Change
finance
MLP Reports Wider Loss Despite Strong Revenue Growth in 2024
by Zacks Equity Research
Maui Land & Pineapple 2024 revenues rise y/y. Net loss widens due to one-time costs. Leasing gains and housing projects highlight long-term potential.
MLPNegative Net Change
earnings finance
AgEagle Trims Loss in 2024 Banking On Record Orders & Cost Cuts
by Zacks Equity Research
UAVS cut losses and boosted gross profit in 2024, securing record drone orders and slashing expenses to strengthen its path to growth.
UAVSPositive Net Change
consumer-staples earnings
ClearOne Slides on Q4 Loss Despite Cost Cuts & Latest Launches
by Zacks Equity Research
The CLRO stock plunges 41% in a month as Q4 revenues rise 18% sequentially but fall y/y. Losses widen amid certification and demand challenges.
CLROPositive Net Change
earnings tech-stocks
TAYD Stock Gains 2% Despite Q3 Earnings Decline Y/Y, Backlog Grows
by Zacks Equity Research
Taylor Devices reports a year-over-year fall in fiscal Q3 earnings amid high interest rates but sees strong backlog growth, highlighting operational resilience and market diversification.
TAYDNegative Net Change
earnings industrial-products
Applied Energetics Posts Wider Y/Y Loss in 2024 as Revenues Slip 7.8%
by Zacks Equity Research
AERG reports a wider y/y 2024 loss on lower revenues and rising costs despite a recent stock gain. Key contracts and cash flow remain under pressure.
AERGNegative Net Change
earnings tech-stocks
TSS Stock Drops 13.2% Despite Record Q4 Earnings & AI Growth
by Zacks Equity Research
TSSI reports record Q4 earnings fueled by AI demand. Yet, the stock falls as investors weigh the profit mix and rising infrastructure costs.
TSSIPositive Net Change
earnings industrial-products
SYPR Slips 4% Despite Q4 Earnings Up Y/Y on Solid Energy Shipments
by Zacks Equity Research
Sypris Solutions reports improved Q4 earnings on a year-over-year basis, fueled by strong energy shipments and margin gains, despite a year-over-year decline in total revenue.
SYPRNegative Net Change
computers earnings tech-stocks
BTTR Stock Down 9% Despite Narrowing Q4 Losses and E-Commerce Gains
by Zacks Equity Research
Better Choice's Q4 loss per share narrows on a year-over-year basis, with 26% sales growth and stronger margins, driven by e-commerce momentum and operational improvements.
earnings retail
BK Technologies Stock Jumps After Strong Q4 Earnings and Outlook
by Zacks Equity Research
BKTI witnesses solid fourth-quarter 2024 results, driven by strong BKR 9000 sales, margin gains and upbeat guidance for 2025.
BKTINegative Net Change
earnings tech-stocks
Comstock's Q4 Earnings Up Y/Y on ParkX Growth, Stock Soar 48%
by Zacks Equity Research
CHCI reports strong Q4 earnings with 54% revenue growth, boosted by robust leasing activity and continued expansion of its ParkX Management subsidiary despite elevated operating costs.
CHCIPositive Net Change
construction earnings
United-Guardian Stock Dips 9.6% Despite Robust 2024 Sales & Earnings
by Zacks Equity Research
UG's 2024 sales grow 12% y/y and earnings rise. Yet. the stock falls amid supply challenges and muted guidance, sparking mixed investor sentiment.
UGPositive Net Change
earnings medical
Cato Stock Improves 16% as Q4 Loss Narrows Year Over Year
by Zacks Equity Research
CATO incurs a narrower year-over-year loss per share in Q4 as improved supply chain efficiency and cost controls help offset sales declines and margin pressures in a challenging retail environment.
CATOPositive Net Change
earnings retail
Team Stock Jumps 20% After Q4 Earnings Rise and Margin Gains
by Zacks Equity Research
TISI posts strong Q4 and 2024 results, with rising margins and improved cash flow. Its shares rise 20% as management projects further growth in 2025.
TISIPositive Net Change
construction earnings
NeurAxis Stock Gains Post Q4 Earnings and Revenue Growth
by Zacks Equity Research
NRXS records strong revenue growth, expanded insurance coverage and new FDA clearances in fourth-quarter 2024.
NRXSNegative Net Change
earnings medical
CVD Equipment Stock Down Despite Y/Y Uptick in Q4 Earnings, Revenues
by Zacks Equity Research
CVV records revenue growth in fourth-quarter 2024, returning to profitability with improved gross margins and stronger segment performance.
CVVNegative Net Change
earnings industrial-products